Because Process Matters

Archive by Author

OpenText in Life Sciences – DIA’s EDM and ERS/eCDT Conference

Posted by: Ethan Smith in: ● October 18, 2012

Last week, OpenText participated in DIA’s EDM and ERS/eCTD conference in Baltimore and what a great event it was! This hybrid conference combined related disciplines to focus holistically on “The Content Continuum from Document Authoring through Submission Delivery” which proved to be highly informative. There were multiple presentations by FDA providing updates on the new [...]

Battling Regulatory Pressures in Life Sciences

Posted by: Ethan Smith in: ● July 26, 2011

It’s no secret that Life Sciences is one of the most highly regulated industries with ever-increasing obligations and scrutiny. As these requirements increase it is essential that you are prepared for changes that you can expect will continue to come. Life Sciences companies should build into their operational structure a plan for continuous change and [...]

A Bumpy Ride for Life Sciences in 2011?

Posted by: Ethan Smith in: ● January 25, 2011

As 2011 gets into full swing, I can’t help but think about the impending federal regulations forcing pharmaceutical companies to document, track and report payments to physician and physician owned entities, set to begin at the end of the year.   In its annual Predicts 2011 series, Gartner recently published  a list of predictions for the [...]

A Prescription for Compliance Controls to Address a $600M Problem

Posted by: Ethan Smith in: ● September 8, 2010

Among the litany of headlines recently blasting pharmaceutical, biotech and medical device companies, Allergan – the makers of Botox – has been the latest scapegoat. The past week’s news has been full of stories relating to Allergan’s agreement to settle “off label promotion” charges to the tune of $600M. While the specifics of pleas and [...]

The BPM approach to Aggregate Spend compliance

Posted by: Ethan Smith in: ● April 27, 2010

In today’s Life Sciences world everything is becoming increasingly more difficult – all of the “easy” drugs have been discovered, the human genome has been mapped and parts even patented (albeit with much dispute), the blockbuster model has crumbled, cost pressures are intensifying and regulatory scrutiny is at an all time high. The cries for [...]

Solving pharma’s 11 billion dollar revenue leakage problem

Posted by: Ethan Smith in: ● January 20, 2010

In lieu of the recent eye-opening study from IDC regarding pharma’s annual revenue leakage, as Metastorm’s Director of Life Sciences Solutions I wish to share the successes of Metastorm’s customers in the life sciences space, to highlight how Metastorm BPM® can (and has) solved this problem, and to improve the financial health of every life [...]


RSS Email Subscription